Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Gross Profit (2020 - 2025)

Historic Gross Profit for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $5.7 million.

  • Maravai Lifesciences Holdings' Gross Profit fell 8245.64% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.5 million, marking a year-over-year decrease of 6831.78%. This contributed to the annual value of $108.3 million for FY2024, which is 2274.79% down from last year.
  • Maravai Lifesciences Holdings' Gross Profit amounted to $5.7 million in Q3 2025, which was down 8245.64% from $7.8 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Gross Profit ranged from a high of $205.2 million in Q2 2022 and a low of $5.7 million during Q3 2025
  • In the last 5 years, Maravai Lifesciences Holdings' Gross Profit had a median value of $39.0 million in 2023 and averaged $86.4 million.
  • Its Gross Profit has fluctuated over the past 5 years, first skyrocketed by 60003.11% in 2021, then plummeted by 8750.66% in 2023.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Gross Profit stood at $189.3 million in 2021, then decreased by 19.99% to $151.5 million in 2022, then crashed by 74.23% to $39.0 million in 2023, then tumbled by 50.32% to $19.4 million in 2024, then plummeted by 70.84% to $5.7 million in 2025.
  • Its Gross Profit was $5.7 million in Q3 2025, compared to $7.8 million in Q2 2025 and $7.7 million in Q1 2025.